1. bookVolume 75 (2021): Issue 2 (April 2021)
Journal Details
License
Format
Journal
First Published
14 Sep 2008
Publication timeframe
6 times per year
Languages
English
access type Open Access

Inherited Thrombophilias in Thrombosis Advancement in Microvascular Flap Surgery

Published Online: 08 May 2021
Page range: 113 - 120
Received: 30 Jul 2020
Accepted: 19 Feb 2021
Journal Details
License
Format
Journal
First Published
14 Sep 2008
Publication timeframe
6 times per year
Languages
English
Abstract

Microvascular flap surgery is a reliable method for reconstructive surgery. To avoid and foresee free flap thrombosis advancement after microvascular flap surgery, patient assessment, flawless surgical technique, and eligible perioperative care are pivotal. In this prospective observational study, we aimed to elucidate the most common inherited single nucleotide polymorphisms (SNPs) attributable to free flap thrombosis. A total of 152 patients undergoing microvascular flap surgery during the study period of 2016–2019 were analysed for five SNPs: rs6025 in Factor V Leiden (FVL) gene, rs1799963 in Factor II (FII) gene, rs2066865 in Fibrinogen Gamma Chain gene (FGG), rs2227589 in SERPINC 1 gene and rs1801133 in Methylene Tetrahydrofolate Reductase (MTHFR) gene. Activated protein C resistance (aPCR), prothrombin, antithrombin (AT), fibrinogen and homocysteine plasma levels were measured to determine association with the analysed SNPs and with free flap thrombosis advancement. Our preliminary results show that carriers of FVL mutation were associated with aPCR, as we observed significantly lower aPCR plasma levels in carriers of genotype C/T, as compared to C/C; p = 0.006 (CI 95%, 0.44 to 1.19). Additionally, mean fibrinogen plasma levels were higher in carriers of FGC gene rs2066865 genotype A/A (5.6 ± 1.81 g/l), as compared to G/A and G/G; p = 0.04 (CI 95%, 0.007 to 1.09); p = 0.004 (CI 95%, 0.48 to 2.49), respectively. The study group included 12 patients (7.9%) with free flap thrombosis. For one patient free flap thrombosis advancement might have been related to the rs6025T – FVL mutation with a PCR plasma level 1.21. Lower aPCR levels was associated with carriers of FVL rs6025 C/T and higher fibrinogen plasma levels with carriers of FGG rs2066865 A/A, suggesting that these genotypes might predict higher free flap thrombosis risk, but we found no significant association between analysed SNPs and free flap thrombosis advancement.

Keywords

Biben, J. A., Atmodiwirjo, P. (2019). Free flap thrombosis in patients with hypercoagulability: A systemic review. Arch. Plastic Surg.,46, 572–579.Search in Google Scholar

Dählback, B. (2008). Advances in understanding pathogenic mechanisms of thrombophilic disorders. Blood, 112 (1), 19–27.Search in Google Scholar

Dahlbäck, B. (2005). Blood coagulation and its regulation by anticoagulant pathways: Genetic pathogenesis of bleeding and thrombotic diseases. J. Int. Med.,257, 209–223.Search in Google Scholar

Dizon-Towson, D., Nelson, L., Jang, H. (1997). The incidence of the factor V Leiden mutation in an obstetric population and its relationship to deep vein thrombosis. Amer. J. Obstet. Gynecol., 176, 883–886.Search in Google Scholar

Drizlionoka, K., Ozoliņa, A., Ņikitina-Zaķe, L., Mamaja, B. (2019). Markers for thrombosis prediction in free flap surgery. Eur. J. Anaesthesiol. E-Supplement, Abstract No.12AP04-3, Vol. 36, Suppl. 57.Search in Google Scholar

Drizlionoka, K., Zarinš, J., Ozolina, A., Nikitina-Zake, L., Mamaja, B. (2019). Polymorphism rs2066865 in the Fibrinogen Gamma Chain (FGG) gene increases plasma fibrinogen concentration and is associated with an increased microvascular thrombosis rate. Medicina,55, 563.Search in Google Scholar

El-Galaly, T. C., Severinsen, M., Overvad, K., Steffensen, R., Vistisen, A. K., Tjønneland, A., Kristensen, S. R. (2013). Single nucleotide polymorphisms and the risk of venous thrombosis: Results from a Danish case-cohort study. Brit. J. Haemat., 160, 838–841.Search in Google Scholar

Falcon, C. R., Cattaneo, M., Panzeri, D., Martinelli, I., Mannucci, P. M. (1994). High prevalence of hyperhomocysteinemia in patients with juvenile venous thrombosis. Atheroscl. Thromb. Vasc. Biol.,14, 1080–1083.Search in Google Scholar

Farrell, D. H. (2012). γ’ Fibrinogen as a novel marker of thrombotic disease. Clin. Chem. Lab. Med.,50, 1903–1909.Search in Google Scholar

Friedman, T., Coon, D. B., Micheals, J. V., Bontempo, F., Young, V. L., Clavijo, J. A., Rubin, J. P. (2010). Hereditery coagulopathies: Practical diagnosis and management for the plastic surgeon. Plastic Reconstr. Surg.,5, 1544–1552.Search in Google Scholar

Henschen, A., Lottspeich, F., Kehl, M., Southan, C. (1983). Covalent structure of fibrinogen. Ann. NY Acad. Sci., 408, 28–43.Search in Google Scholar

Liew, S. C., Gupta, E. D. (2015). Methylenetetrahydrofolate reductase (MTHFR) C667T polymorphism: Epidemiology, metabolism and the associated diseases. Eur. J. Med. Gen., 58, 1–10.Search in Google Scholar

Livak, K. J. (1999). Allelic discrimination using fluorogenic probes and the 5’nuclease assay. Genet. Anal.,14, 143–149.Search in Google Scholar

van der Meer, J., Stoepman-van Dalen, E. A., Jansen, J. M. S. (1973). Antithrombin-III deficiency in a Dutch family. J. Clin. Pathol., 26 (7), 532–538.Search in Google Scholar

Meltzer, M. E., Lisman, T., de Groot, P. G., Meijers, M. C., le Cessie,S., Doggen, C. J., Rosendaal, F. R. (2010). Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1. Blood.,116, 113–121.Search in Google Scholar

Pannuci, C. J., Kovach, S. J., Cuker, A. (2015). Microsurgery and hypercoagulable state. A haematologist perspective. Plast. Reconstr. Surg.,4, 545–552.Search in Google Scholar

Pathare, A., Alkindi, S., Albalushi, T., Bayoumi, R., Dennisoni, D., Muralitharan, S. (2004). Heterozygous methylene tetrahydrofolate reductase mutation with mild hyperhomocysteinemia associated with deep vein thrombosis. Clin. Lab. Haem.,26, 143–146.Search in Google Scholar

Patnaik, M. M., Moll, S. (2008). Inherited antithrombin deficiency: A review. Haemophilia, 14 (6), 1229–1239.Search in Google Scholar

Poort, S. R., Rosendaal, F. R., Reitsma, P. H., Bertina, R. M. (1996). A common genetic variation in the 3’- untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood,88, 3698–3703.Search in Google Scholar

Ray, J. G., Shmorgun, D., Chan, W. S. (2002). Common C677T polymorphism of the methylene tetrahydrofolate reductase gene and the risk of venous thromboembolism: Metaanalysis of 31 studies. Pathophysiol. Haemost. Thromb., 32, 51–58.Search in Google Scholar

Rees, D., Cox, M., Clegg, J. (1995). World distribution of factor V Leiden. Lancet,346, 1133–1134.Search in Google Scholar

Ridker, P. M., Glynn, R., Miletich, J. (1997). Age specific incidence rates of venous thromboembolism among heterozygous carriers of factor V Leiden mutation. Ann. Intern. Med.,126, 528–531.Search in Google Scholar

Ridker, P. M., Miletich, J. P., Hennekens, C. H., Buring, J. E. (1997). Ethnic distribution of factor V Leiden in 4047 men and women: Implications for venous thromboembolism screening. JAMA, 277, 1305–1307.Search in Google Scholar

Rosenberg, N., Murata, M., Ikeda, Y., Opare-Sem, O., Zivelin, A., Geffen, E. (2002). The frequent 5, 10-methylenetetrahydrofolate reductase C667T polymorphism is associated with common haplotype in Whites, Japanese and Africans. Amer. J. Hum. Genet., 70, 758–762.Search in Google Scholar

Rosendaal, F. R., Doggen, C. J. M., Zivelin, A., Arruda, V. R., Aiach, M., Siscovick, D. S., Hillarp, A., Watzke, H. H., Bernardi, F., Cumming, A. M., Preston, F. E., Reitsma, P. H. (1998). Geographic distribution of the 20210 G to a prothrombin variant. Thromb. Haemost., 79, 706–708.Search in Google Scholar

Rosendaal, F. R., Koster T., Vandenbroucke J., Reitsma P. (1995). High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood, 85, 1504–1508.Search in Google Scholar

Rozen, R. (1997). Genetic predisposition to hyperhomocysteinaemia: Deficiency of methylenetetrahydrofolate reductase (MTHFR). Thromb Haemost.,78, 523–536.Search in Google Scholar

Slavik, L., Krcova, V., Hlusi, A., Prochazkova, J., Prochazka, M., Ulehlova, J., Indrak K. (2009). Molekular pathophysiology of thrombotic states and their impact to laboratory diagnostics. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub., 153 (1), 19–26.Search in Google Scholar

Segers, K., Dahlbäck, B., Nicolaes, G. (2007). Coagulation factor V and thrombophilia: Background and mechanisms. Thromb. Haemost., 98, 530–542.Search in Google Scholar

Stanger, O., Herrman, W., Pietrzik, K., Fowler, B., Giesel, J., Dierkes, J. (2004). Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases. Z. Kardiol., 93, 439–453.Search in Google Scholar

Svensson, P., Dahlbäck, B. (1994). Resistance to activated protein C as a basis for venous thrombosis. New Engl. J. Med., 330 (8), 517–522.Search in Google Scholar

Undas, A., Casini, A. (2019). Congenital structural and functional fibrinogen disorders: A primer for internists. Pol. Arch. Intern. Med., 129 (12), 913–920.Search in Google Scholar

Welsch, G., Upchurch, G., Loscalzo, J. (1997). Hyperhomocysteinaemia and atherothrombosis. Ann. NY Acad. Sci., 81, 48–58.Search in Google Scholar

Vanags, I., Stepanovs, J., Ozolina, A., Mukans, M., Bjertnaes, L. J., Mamaja, B. (2020). Thromboelastometry for assessing risks of free flap thrombosis in patients undergoing microvascular surgery. Front. Med.,7, 289.Search in Google Scholar

Xuan, C., Bai, X. Y., Gao, G., Yang, Q., He, G. W. (2011). Association between polymorphism methylenetetrahydrofolate reductase (MTHFR) C677T and risk of myocardial infarction: A meta-analysis for 8,140 cases and 10,522 controls. Arch. Med. Res.,42, 677–685.Search in Google Scholar

Zöller, B., Dahlbäck, B. (1994). Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis. Lancet, 343, 1536–1538.Search in Google Scholar

Zöller, B., Garcia de Frutos, P., Hillarp, A., Dählback, B. (1999). Thrombophilia as a multigenic disease. Haematologica,84, 59–70.Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo